- 24 Tech Roqad st Ny 10023
- editech@mail.com
Our Board of Directors comprises industry veterans and strategic leaders who guide Cohance’s vision and growth. Their expertise spans pharmaceuticals, private equity, and corporate governance, ensuring we remain a trusted partner in health science innovation.
Mr. Venkateswarlu Jasti holds postgraduate degrees in Pharmacy from Andhra University, Visakhapatnam, and St. John’s University, New York, specializing in Industrial Pharmacy.
A pioneer of the CRAMS business model in India, Mr. Jasti founded Suven Pharma Ltd. and Suven Life Sciences Ltd., leading their growth since inception in 1989. Under his leadership, Suven Life Sciences developed a robust discovery pipeline, including SUVN-502 (Phase 3 trials in the US for Alzheimer’s-related agitation) and SUVN-G3031 (Phase 2 completed for narcolepsy).
He has played instrumental roles in forming the AP Chief Minister’s Task Force for Pharma, establishing Pharma City in Visakhapatnam, and launching PHARMEXCIL. He has held leadership positions in industry associations such as the Indian Pharmaceutical Association and the Bulk Drug Manufacturers Association of India.